Anda belum login :: 04 Jun 2025 23:44 WIB
Detail
ArtikelSkeletal Muscle Depletion Is Associated with Reduced Plasma (n-3) Fatty Acids in Non-Small Cell Lung Cancer Patients  
Oleh: Murphy, Rachel A. ; Mourtzakis, Marina ; Chu, Quincy S.
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: JN: The Journal of Nutrition vol. 140 no. 09 (Sep. 2010), page 1602-1606 .
Topik: Skeletal Muscle; Lung Cancer
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: J42.K
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelUpwards of 50% of newly diagnosed advanced lung cancer patients have severe muscle wasting (sarcopenia). Supplementation with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in advanced cancer has been shown to attenuate lean tissue wasting. However, the relationship between muscle mass and plasma (n-3) fatty acids in the absence of supplementation is unclear. We aimed to determine how plasma phospholipid (n-3) fatty acids relate to sarcopenia and change in muscle mass in non-small cell lung cancer patients receiving chemotherapy. Computed tomography images were used to measure muscle mass. Patients were classified as sarcopenic or nonsarcopenic based on sex-specific cutpoints. Change in muscle mass during chemotherapy (2.5 mo) was calculated and patients were divided into quartiles based on the rate of muscle loss or gain. Patients with sarcopenia had lower plasma EPA (16.7 ± 2.1 µmol/L vs. 31.6 ± 4.4 µmol/L; P = 0.001), DHA (36.6 ± 4.0 µmol/L vs. 55.3 ± 4.0 µmol/L; P = 0.003), and sum (n-3) fatty acids (63.6 ± 5.6 µmol/L vs. 95.0 ± 7.7 µmol/L; P = 0.002) than nonsarcopenic patients. Patients with maximal muscle loss (mean - 3.5 kg) had lower plasma EPA (12.2 ± 3.3 µmol/L vs. 35.0 ± 7.1 µmol/L; P = 0.03), DHA (26.9 ± 8.7 µmol/L vs. 59.6 ± 5.3 µmol/L; P = 0.01), and sum (n-3) fatty acids (57.8 ± 13.5 µmol/L vs. 104.6 ± 11.1 µmol/L; P = 0.005) compared with patients who were gaining muscle (mean +1 kg). Plasma (n-3) fatty acids are depleted in cancer patients with sarcopenia, which may contribute to accelerated rates of muscle loss.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.015625 second(s)